Paediatric Infectious Disease
Melinta Therapeutics LLC focuses on clinical research in acute bacterial skin and skin structure infections affecting children, with attention to treatment options for paediatric patients requiring hospital-based care.
- Acute ABSSSI
- Paediatric infection management
- Skin and soft tissue infections
The sponsor’s research activity is centred on evaluating intravenous anti-infective therapy in a multinational network of sites.
Antibacterial Therapy
The clinical programme includes interest in oritavancin for bacterial skin infections, reflecting a therapeutic emphasis on gram-positive bacterial coverage and treatment of serious skin and skin structure infections.
- Oritavancin
- Intravenous antibacterial treatment
- Gram-positive pathogens
This area aligns with the sponsor’s work in developing therapies for infections that require effective systemic antibacterial intervention.
Hospital and Acute Care Infections
Research activity is directed toward infections managed in acute care settings, with clinical interest in patients presenting with skin and soft tissue bacterial disease that may need prompt treatment and monitoring.
- Acute care infection treatment
- Hospital-based infectious disease care
- Systemic bacterial infections
The sponsor’s trial footprint spans multiple collaborating sites across several countries, supporting investigation of infection therapies in varied clinical environments.
